Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-11-18 00:00:00 ET · period of report 2021-11-16 · accession 0001237899-21-000024 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-11-18 | 2021-11-16+ | REGN | SING GEORGE L | Dir | S - Sale | $653.76 | -10.0K | 32.9K | -23% | -$6.54M |
| I | 2021-11-18 | 2021-11-16 | REGN | SING GEORGE L | Dir | S - Sale | $650.00 | -750 | 1,000 | -43% | -$487.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-16 | S | D | 2,000 | $650.00 | 40,858 | D by Trust for Son | — | — | |
| 2 | Common | Common Stock | 2021-11-16 | S | D | 2,000 | $658.79 | 38,858 | D | — | — | |
| 3 | Common | Common Stock | 2021-11-16 | S | D | 2,000 | $660.00 | 36,858 | D | — | — | (F1) Represents volume-weighted average price of sales of 2,000 shares of Company stock on November 16, 2021 at prices ranging from $660.00 to $660.24. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. |
| 4 | Common | Common Stock | 2021-11-18 | S | D | 4,000 | $650.00 | 32,858 | D | — | — | |
| 5 | Common | Common Stock | 2021-11-16 | S | D | 750 | $650.00 | 1,000 | I | — | — |